Johnson & Johnson to acquire V-Wave Ltd. in $1.1bn deal to enhance heart failure treatment

Johnson & Johnson (NYSE: JNJ) has made headlines with its decision to acquire V-Wave Ltd., a private company renowned for its cutting-edge treatments for heart ... Read More